Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0JAV stock hub

LON/0JAV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0JAVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.1B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0JAV

In the news

Latest news · LON/0JAV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-294.5

P25 -54.2P50 2.1P75 13.7

ROIC-42.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0JAV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	1,664
Employees Change	359%
Employees Change Percent	39.36
Enterprise value	$15.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US4576693075
Last refreshed	2026-05-10
Market cap	$16.1B
Price	$101
Price currency	USD
Rev Per Employee	372,992.74x
Sector	Healthcare
Sic	2836
Symbol	lon/0JAV
Website	https://www.insmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.56%
EV Earnings	-17.59x
EV/FCF	-22.59x
EV/Sales	26.22x
FCF yield	-4.33%
P/B ratio	30.2x
P/S ratio	25.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-117.77%
EBITDA Margin	-115.8%
Gross margin	81.81%
Gross Profit	$507.8M
Gross Profit Growth	130.04%
Gross Profit Growth Q	261.37%
Gross Profit Growth3 Y	49.49%
Gross Profit Growth5 Y	36.55%
Net Income	$-896.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-143.76%
Profit Margin	-144.44%
Profit Per Employee	$-538,740
ROA	-31.11
Roa5y	-25.98
ROCE	-56.29
ROE	-294.5
ROIC	-42.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	47.79%
Cagr3y	72.92%
Cagr5y	23.83%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	115.09x
Revenue Growth Q	229.62x
Revenue Growth Quarters	21x
Revenue Growth Years	7x
Revenue Growth3 Y	47.1x
Revenue Growth5 Y	37.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$1.6B
Cash	$926.6M
Current Assets	$1.2B
Current Liabilities	$264.8M
Debt	$562.3M
Debt Equity	$1.05
Debt FCF	$-0.81
Equity	$533.8M
Interest Coverage	-11.73
Liabilities	$1B
Long Term Assets	$388.8M
Long Term Liabilities	$773.5M
Net Cash	$364.3M
Net Cash By Market Cap	$2.26
Net Debt Equity	$-0.68
Tangible Book Value	$374.9M
Tangible Book Value Per Share	$1.73
WACC	9.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.47
Inventory Turnover	1.28
Net Working Capital	$28.1M
Quick ratio	3.88
Working Capital	$948.3M
Working Capital Turnover	$0.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.64%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	47.75%
200-day SMA	155
3Y total return	417.24%
50-day SMA	144
50-day SMA vs 200-day SMA	50under200
5Y total return	191.13%
All Time High	214
All Time High Change	-52.6%
All Time High Date	2025-12-02
All Time Low	16.59
All Time Low Change	511.58%
All Time Low Date	2023-03-27
ATR	8.3
Beta	0.89
Ch YTD	-41.77
High	109
High52	214
High52 Date	2025-12-02
High52ch	-52.6%
Low	101
Low52	63.94
Low52 Date	2025-05-08
Low52ch	58.63%
Ma50ch	-29.57%
Price vs 200-day SMA	-34.56%
RSI	20.23
RSI Monthly	47.8
RSI Weekly	29.53
Sharpe ratio	0.81x
Sortino ratio	1.34
Total Return	-20.64%
Tr YTD	-41.77
Tr1m	-38.04%
Tr1w	-24.94%
Tr3m	-33.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-731M
Operating margin	-117.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	194,394,629%
Net Borrowing	-3,681,506.8
Shares Insiders	0.62%
Shares Institutions	91.58%
Shares Qo Q	0.86%
Shares Yo Y	20.64%
Short Ratio	5.5

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-818.5M
Average Volume	914.8x
Bv Per Share	2.47
CAPEX	$-19.7M
Ch1m	-38.04
Ch1w	-24.94
Ch1y	47.75
Ch3m	-33.27
Ch3y	417.2
Ch5y	191.1
Ch6m	-44.89
Change	-10.55%
Change From Open	-6.08
Close	113.4
Days Gap	-4.75
Depreciation Amortization	11,868,990
Dollar Volume	121,310.3
Earnings Date	2026-05-07
EBIT	$-731M
EBITDA	$-718.7M
EPS	$-4.32
F Score	4
FCF	$-698M
FCF EV Yield	-4.43x
Financing CF	722,915,023
Fiscal Year End	December
Founded	1,988
Goodwill	99,838,590.5
Income Tax	$4.2M
Investing CF	91,280,244
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	163.8
Ma150ch	-38.09%
Ma20	137.4
Ma20ch	-26.17%
Net CF	135,512,914
Open	108
Position In Range	5.35
Ppne	149,807,764.8
Price Date	2026-05-08
Ptbv Ratio	43.01
Relative Volume	1.17x
Revenue	620,659,915x
SBC By Revenue	19.43x
Share Based Comp	120,564,471
Tax By Revenue	0.68x
Tr6m	-44.89%
Volume	1,196
Z Score	7.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0JAV pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0JAV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0JAV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+91.6%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0JAV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

20.2

Below 30: short-term oversold

Price vs 200-day MA

-34.6%

50/200-day relationship not available

Beta (5Y)

0.89

Moves roughly with the market

Sharpe ratio

0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0JAV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0JAV stock rating?

lon/0JAV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0JAV analysis?

The full report lives at /stocks/lon/0JAV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0JAV?

The latest report frames lon/0JAV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0JAV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.